Efficacy of Myo-inositol in Preventing Gestational Diabetes in High-risk Pregnant Women
This study is currently recruiting participants.
Verified January 2012 by AGUNCO Obstetrics and Gynecology Centre
Sponsor:
AGUNCO Obstetrics and Gynecology Centre
Information provided by (Responsible Party):
AGUNCO Obstetrics and Gynecology Centre
ClinicalTrials.gov Identifier:
NCT01511835
First received: November 16, 2011
Last updated: January 13, 2012
Last verified: January 2012
| Tracking Information | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| First Received Date ICMJE | November 16, 2011 | ||||||||
| Last Updated Date | January 13, 2012 | ||||||||
| Start Date ICMJE | Not Provided | ||||||||
| Primary Completion Date | Not Provided | ||||||||
| Current Primary Outcome Measures ICMJE |
OGTT The diagnostic 75g oral glucose tolerance test (OGTT) is performed between 24 and 28 weeks of gestation. |
||||||||
| Original Primary Outcome Measures ICMJE | Same as current | ||||||||
| Change History | Complete list of historical versions of study NCT01511835 on ClinicalTrials.gov Archive Site | ||||||||
| Current Secondary Outcome Measures ICMJE |
|
||||||||
| Original Secondary Outcome Measures ICMJE | Same as current | ||||||||
| Current Other Outcome Measures ICMJE | Not Provided | ||||||||
| Original Other Outcome Measures ICMJE | Not Provided | ||||||||
| Descriptive Information | |||||||||
| Brief Title ICMJE | Efficacy of Myo-inositol in Preventing Gestational Diabetes in High-risk Pregnant Women | ||||||||
| Official Title ICMJE | Not Provided | ||||||||
| Brief Summary | The aim of this study is to evaluate the efficacy of myo-inositol in preventing gestational diabetes in high risk pregnant women. |
||||||||
| Detailed Description | Not Provided | ||||||||
| Study Type ICMJE | Interventional | ||||||||
| Study Phase | Phase 4 | ||||||||
| Study Design ICMJE | Not Provided | ||||||||
| Condition ICMJE | Gestational Diabetes | ||||||||
| Intervention ICMJE |
|
||||||||
| Study Arm (s) |
|
||||||||
| Publications * |
|
||||||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||||||
| Recruitment Information | |||||||||
| Recruitment Status ICMJE | Recruiting | ||||||||
| Enrollment ICMJE | Not Provided | ||||||||
| Completion Date | Not Provided | ||||||||
| Primary Completion Date | Not Provided | ||||||||
| Eligibility Criteria ICMJE | Inclusion Criteria: 60 women in their first trimester of pregnancy affected by one or more of the following risk factors:
Exclusion Criteria:
|
||||||||
| Gender | Female | ||||||||
| Ages | 20 Years to 45 Years | ||||||||
| Accepts Healthy Volunteers | Not Provided | ||||||||
| Contacts ICMJE |
|
||||||||
| Location Countries ICMJE | Italy | ||||||||
| Administrative Information | |||||||||
| NCT Number ICMJE | NCT01511835 | ||||||||
| Other Study ID Numbers ICMJE | MyoIN_diab | ||||||||
| Has Data Monitoring Committee | Not Provided | ||||||||
| Responsible Party | AGUNCO Obstetrics and Gynecology Centre | ||||||||
| Study Sponsor ICMJE | AGUNCO Obstetrics and Gynecology Centre | ||||||||
| Collaborators ICMJE | Not Provided | ||||||||
| Investigators ICMJE | Not Provided | ||||||||
| Information Provided By | AGUNCO Obstetrics and Gynecology Centre | ||||||||
| Verification Date | January 2012 | ||||||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||||||